- Home
- GOAI vs KRRO Comparison
GOAI vs KRRO Comparison
Compare GOAI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.44
HOLD
Current Price
$12.11
Company Overview
Basic Information| Metric | GOAI | KRRO |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.9M | 101.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GOAI | KRRO |
|---|---|---|
| Price | $5.44 | $12.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $47.10 |
| AVG Volume (30 Days) | 114.5K | ★ 230.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,271,000.00 |
| Revenue This Year | N/A | $145.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.75 | $5.20 |
| 52 Week High | $5.70 | $55.89 |
Technical Indicators
Market Signals| Indicator | GOAI | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 68.28 | 55.57 |
| Support Level | $3.95 | $10.55 |
| Resistance Level | N/A | $15.05 |
| Average True Range (ATR) | 0.71 | 0.93 |
| MACD | 0.13 | -0.10 |
| Stochastic Oscillator | 99.64 | 59.58 |
Price Performance
Historical Comparison GOAI
KRRO
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.